Tony Oosterveen

Tony Oosterveen has a diverse background in scientific research and project management. Tony is currently working at bit.bio as a Principal Scientist since June 2022. In their previous role at bit.bio, they served as a Senior Scientist and team lead in neurobiology from August 2019 to June 2022. In this position, they managed a team of scientists and technicians to develop cellular reprogramming strategies for generating specific neuronal subtypes and glial cells from iPSCs. These models were used to study neuronal function and neurological diseases.

Before joining bit.bio, Tony was a Senior Scientist and CNS specialist at Synpromics Ltd from an unspecified date in 2018 to August 2019. Tony worked as a project manager, leading different projects that utilized genomic data and computational approaches to design custom synthetic regulatory elements for targeted gene expression in the central nervous system (CNS). These regulatory elements were used for the development of gene therapies for neurological disorders.

Prior to their role at Synpromics Ltd, Tony worked at Ixion as a Medical Innovation Specialist from an unspecified date in 2017 to 2018. In this position, they assisted small and medium-sized enterprises in securing funding for medical concepts. Tony successfully obtained EU grants totaling around €6m, including prestigious grants such as Dedicated SME Instrument phase 2 and Eurostars grants.

Tony also has experience working at the Medical Research Council, where they served as a Senior Investigator Scientist from January 2013 to an unspecified date in 2017. In this role, they co-managed a research group, supervised staff, and led a research project focused on using in vitro differentiation of human embryonic and induced pluripotent stem cells to model Parkinson's disease. Their research contributions led to co-authorship on a "Cell Reports" article and other high-impact manuscripts.

Earlier in their career, Tony held positions as a post-doctoral fellow at the Karolinska Institute from September 2004 to December 2012, where they managed successful projects uncovering transcriptional mechanisms in stem cell specification. Tony also worked as a Post-doc at the Hubrecht Institute from 2002 to 2004, and as a Ph.D. student at the Hubrecht Institute, specializing in Developmental Biology and Stem Cell Research from 1997 to 2002.

Tony's career in scientific research began with their undergraduate studies at RUG, where they were a student from 1993 to 1996.

Throughout their career, Tony Oosterveen has demonstrated expertise in cellular reprogramming, neurobiology, gene expression regulation, and funding acquisition for medical innovations.

Tony Oosterveen obtained a PhD in Developmental Genetics from Utrecht University. Prior to that, they completed their Master's degree at the University of Groningen from 1993 to 1997. Before pursuing their Master's degree, Tony attended Hanzehogeschool Groningen / Hanze University of Applied Sciences Groningen from 1989 to 1993, although the specific degree and field of study are not provided.